New software could speed up CMV diagnosis in pregnant women

NCT ID NCT06694428

Recruiting now Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a decision-support tool called MyCMV that helps doctors interpret blood test results for cytomegalovirus (CMV) infection during pregnancy. CMV is a common virus that can cause hearing loss and developmental problems in babies if the mother catches it for the first time while pregnant. The tool aims to speed up diagnosis so that treatment can start earlier. About 491 pregnant women with positive or borderline CMV test results will take part, and the tool's accuracy will be compared to expert interpretation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cytomegalovirus infection disease Infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYTOMEGALOVIRUS INFECTIONS MATERNAL PRIMARY CYTOMEGALOVIRUS INFECTION

Contacts and locations

Locations

CHU de Limoges
RECRUITING

Limoges, 87000, France
Hôpital Necker-Enfants Malades
RECRUITING

Paris, 75015, France
Hôpital Paul Brousse
RECRUITING

Villejuif, 94804, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.